天天舔天天爽_视频日韩_成人网线_天天草草草_免费一级在线观看_色综合色综合色综合色综合

美國Integrated Diagnostics
Integrated Diagnostics 正在開發(fā)基于血液的大規(guī)模分子診斷技術(shù)，該技術(shù)通過同時監(jiān)測數(shù)十到數(shù)百個疾病標(biāo)記物，實現(xiàn)重大疾病，如肺癌和阿爾茨海默氏癥的早期檢測。該公司由系統(tǒng)生物學(xué)先驅(qū) Lee Hood 博士于 2009 年 10 月創(chuàng)立，公司正致力于通過采用尖端信息學(xué)技術(shù)進行生物標(biāo)記物選擇，以及采用創(chuàng)新的具有類似抗體特性的合成診斷和治療劑——蛋白質(zhì)催化的捕獲劑，開發(fā)新一代個體化醫(yī)療解決方案。Integrated Diagnostics 的目標(biāo)是開發(fā)用于嚴(yán)重疾病早期檢測的新一代低成本、大規(guī)模診斷分析技術(shù)。該公司專注于從系統(tǒng)生物學(xué)角度研究包含蛋白質(zhì)、基因及其他分子的疾病病理生理學(xué)分子網(wǎng)絡(luò)。投資者包括 InterWest Partners、The Wellcome Trust 和 BioTechCube Luxembourg?；A(chǔ)知識產(chǎn)權(quán)由系統(tǒng)生物學(xué)研究所和加州理工學(xué)院獨家授權(quán)。






Integrated Diagnostics is developing large-scale, blood-based molecular diagnostics that detect important diseases like lung cancer and Alzheimer's at their earliest stages by simultaneously monitoring tens to hundreds of disease markers. The company, founded in October 2009 by systems biology pioneerDr. Lee Hood, is creating a new generation of personalized medical solutions using sophisticated informatics for biomarker selection and a novel class of synthetically created diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. Integrated Diagnostics' mission is to build a new generation of low-cost, large-scale diagnostic assays for early detection of serious diseases. The company is conceptually based on a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes, and other molecules. Investors include InterWest Partners, The Wellcome Trust, and BioTechCube Luxembourg. Foundational intellectual property is exclusively licensed from the Institute of Systems Biology and Caltech.